Contraindications include personal or family history of medullary thyroid carcinoma, MEN-2, prior severe hypersensitivity to GLP-1s, history of pancreatitis, severe gastroparesis, and pregnancy or breastfeeding
[DOI] [PubMed] [Google Scholar] 333
And in medical research, even the smallest difference can change the results and make like-for-like comparisons impossible
Rather, they reflect changes in gene expression patterns, indicating which genes are activated or suppressed, and to what extent
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): data from randomized controlled trials
By activating all three receptors, Retatrutide aims to deliver superior appetite suppression, improved insulin sensitivity, and enhanced energy metabolism, which may lead to more substantial and sustained weight loss compared to single-pathway therapies